Stock Analysis

Analyst Note: IMAX enters 2026 as the primary beneficiary of the “experience-first” cinema economy. With a record backlog of system installations in China and Southeast Asia, and a dominant Global Box Office share for blockbuster releases, the company is effectively decoupling from the broader decline in traditional theater attendance. High-margin technology licensing and the expansion of the Stream-to-IMAX platform provide a scalable software-like revenue stream, supporting a significant re-rating towards our $35 target.

Analyst Note: Veracyte (VCYT) enters 2026 as a top-tier oncology diagnostics pick. Growth is fueled by the dominant Decipher prostate cancer test and the strategic expansion of the Afirma platform. With adjusted EBITDA margins scaling to 25%, VCYT offers a high-conviction entry point into the genomic precision medicine cycle.

Analyst Note: Applied Materials (AMAT) stands as a primary beneficiary of the Angstrom-era chip manufacturing transition. As a dominant provider of Wafer Fabrication Equipment (WFE), AMAT is uniquely positioned to capture value from the surge in GAA transistor architecture and Advanced Packaging demand driven by AI scaling.

Analyst Note: SLB enters 2026 as a premier Energy Tech leader. With the integration of ChampionX complete and the rapid adoption of its Delfi AI platform, the company is positioned to outperform as global energy investment shifts toward efficiency and digitalization.

Analyst Note: Enova International ($ENVA) is a premier AI-driven fintech. Leveraging its proprietary machine learning platform, Colossus, Enova maintains superior credit risk management. With double-digit loan growth and robust buyback programs, $ENVA offers a high-conviction value play.

Analyst Note: Leonardo ($LDO) has successfully reached our price target of $60.00. The investment thesis based on the European defense spending super-cycle has played out perfectly, delivering a 23.71% return. We recommend locking in profits or adjusting stop-losses.